Tue, April 18, 2023
Mon, April 17, 2023
Sun, April 16, 2023
Fri, April 14, 2023
Thu, April 13, 2023

Raghuram Selvaraju Reiterated (AXSM) at Strong Buy and Held Target at $200 on, Apr 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-200-on-apr-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $200 on, Apr 17th, 2023.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 2 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $83 on, Wednesday, April 12th, 2023
  • David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023


These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $84 on, Monday, March 13th, 2023
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, February 28th, 2023
  • Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022

Publication Contributing Sources